The occurrence of intracellular A ␤ accumulation has recently been shown by several groups in different transgenic mouse models and in postmortem tissue of Alzheimer's disease (AD) patients [1] [2] [3] [4] [5] . The nature of these accumulations, however, and whether they are toxic, needs further exploration. Our newly reported transgenic mouse model, the ArcA ␤ mouse that overexpresses human APP 695 with the Swedish and Arctic mutations in a single construct, showed consistent behavioral deficits before the deposition of ␤ -amyloid plaques. These deficits correlated with a rise in intracellular punctate deposits of A ␤ , most prominently in hippocampal, subicular and cortical regions [6] . To further elucidate the subcellular localization of these punctate A ␤ deposits, we performed immunohistological double-staining with various organelle markers including flotillin-1 (reggie-2). Flotillin-1 belongs to the prohibitin (PHB) family of proteins that include flotillin-2, stomatins and others [7, 8] . Flotillins are lipid raft associated proteins [9] and are found at the plasma membrane and in endosomes and multivesicular bodies [10] [11] [12] . We provide evidence that intracellular A ␤ accumulates in flotillin-1 positive vesi-cles and that flotillin-1 is also localized in neuritic ␤ -amyloid plaques of AD patient brains.
Materials and Methods

Transgenic Mice
In this study, ArcA ␤ mice previously described in Knobloch et al. [6] and their wt littermates were used. In brief, tg mice show about 6-fold overexpression of human APP695 containing the Swe (K670N + M671L) and Arc mutations (E693G) under the control of the prion-protein promoter, with constant levels of fulllength APP and age-dependent increases in A ␤ .
Immunostaining and Confocal Fluorescence Microscopy
Coverslip-grown Hela cells were fixed with 3.7% paraformaldehyde (PFA), washed with ammonium chloride, permeabilized with 0.1% Triton X-100 for 5 min, washed with PBS and blocked for 1 h with 0.2% BSA/0.2% Fish Skin Gelatin in PBS (blocking buffer). Cells were then incubated with primary antibodies (rabbit anti-flotillin-1, mouse anti-EEA-1 or mouse anti-giantin or mouse anti-Lamp) in blocking buffer for 1 h, subsequently washed thoroughly with PBS and the primary signal was detected with various fluorochrome (Cy3 or Cy5) conjugated anti-mouse or anti-rabbit antibodies. The images were acquired using Zeiss confocal microscope, LSM510.
Immunohistology
Mice were anesthetized (10 ml/g BW ketamine/xylaxine) and perfused transcardially with PBS. One hemisphere was fixed in 4% paraformaldehyde and embedded in paraffin. 5-m sagittal sections were cut with a Leica RM 2135 microtome (Bannockburn, Ill., USA). Microwave pretreatment (10 min 85 ° C in citrate buffer) and 5 min submersions in 95% formic acid (FA) were done before immunostaining. After blocking of non-specific binding with 4% BSA, 5% goat serum and 5% horse serum at RT for 1 h, sections were incubated with both primary antibodies overnight at 4 ° C (6E10, Signet, 1: 400; anti-A ␤ 40, Sigma, 1: 200; Flotillin-1, BD Biosciences, Germany, 1: 400). After washing with PBS, sections were incubated with fluorophore-conjugated antibodies for 2 h at room temperature (Cy5, 1: 250, Cy2, 1: 100, Jackson) and laser confocal microscopy was performed with a Leica TCS SP2.
Histology and Immunochemistry on Human Autopsy Tissues
The cases included 5 control brains (including 1 case with Parkinson's disease) and 6 cases with AD CERAD scores B-C). 5 m thick sections of formalin-fixed and paraffin-embedded autopsy tissues of the left hippocampus and/or left parietal cortex of human brains were deparaffinized, stained with Gallyas silver stain [13] (reagents from Merck, Darmstadt, Germany) followed by immunochemistry for flotillin-1 or control conditions. The slides were first immersed in concentrated formic acid for 3 min, rinsed with PBS and then cooked in a vapor cooking apparatus (Multigourmet, Braun, Kronberg, Germany) for 20 min in 10 m M sodium citrate with 0.01% Tween, pH 6.5. The primary antibody was applied at a dilution of 1/100 overnight at 4 ° C. Development followed using the ABC indirect alkaline phosphatase kit rabbit IgG (Vector, Burlingame, Calif., USA) and Neu-Fuchsin (Sigma, St.Louis, Mo., USA) as a chromogen [14] .
Results
Intracellular Punctate Deposits of A ␤ in ArcA ␤ Mice Accumulate in Flotillin-1-Positive Vesicles
␤ -Amyloid plaque deposition and cerebral amyloid angiopathy are prominent features in ArcA ␤ mice between 9 and 15 months. Behavioral deficits, however, occur much earlier; these correlate with intracellular punctate A ␤ deposits revealed by labeling with antibodies directed against the A ␤ domain and the failure of APP C-terminal antibodies to stain these structures [6] . These intracellular A ␤ deposits are visible from 3 months onward in the hippocampus, subiculum and cortex but are undetectable in the cerebellum and brainstem, the latter being brain regions unaffected in AD.
Double-staining of brain sections of 7-month-old ArcA ␤ mice showed intracellular punctate A ␤ (6E10, blue) that were frequently surrounded by flotillin-1 (green)-positive structures ( fig. 1 ). The flotillin staining did not fully encircle the A ␤ deposits but rather concentrated in several patches at the edge of the A ␤ deposits. The 6E10 antibody also detects sAPP ␣ ; therefore, we additionally stained with an antibody specific for A ␤ 40 (insert in upper panel of fig. 1 ), clearly identifying intracellular deposits as A ␤ .
Flotillin-1 Is Associated with Early and Late Endosomes in the Endocytic Pathway
To further analyze the nature of the flotillin-positive vesicles, we characterized these vesicles in a cell culture system. We used HeLa cells to colocalize endogenous flotillin with various subcellular markers ( fig. 2 ). Partial overlap of flotillin was seen with the early endosomal marker, early endosomal antigen-1 (EEA-1) and a significant overlap with Lamp-1, a marker for late endosomes and lysosomes. However, no significant colocalization was observed with giantin, a Golgi marker. Colocalization of flotillin with several organelle-specific rabGTPases showed that flotillin predominantly labeled the late endosomes (data not shown), consistent with other reports [11] . We and others have previously shown that A ␤ peptides are found in multivesicular bodies (MVBs) and fusion of MVBs with the plasma membrane releases a minor amount of A ␤ in association with exosomes [15, 16] . Together these data suggest that intracellular A ␤ resides in late endosomes/MVBs.
Flotillin-1 Is Enriched in Neuritic Plaques of AD Patients
As a result of MVB fusion with the plasma membrane, the exosomes that contain A ␤ together with flotillin are released and might participate in ␤ -amyloid plaque formation. We analyzed the distribution of flotillin-1 in brain sections of AD and Parkinson's disease patients and control subjects as described [16] . Most AD cases showed swollen, vacuolated, or tangle-bearing neurons with strong flotillin-1-expression ( fig. 3 a) . There was immunoreaction (IR) in the processes of single astrocytes within the gray matter of areas showing degenerative pathology ( fig. 3 b) . The flotillin-1-positive astrocytes consisted mainly of cells with a nucleus slightly increased in size and with less chromatin density, pointing towards a partial activation. Diffuse ␤ -amyloid plaques showed mostly no increase of flotillin-IR over the matrix background. However, neuritic tangle-bearing plaques often showed increased flotillin-1-IR organized along the fibrillary component of the plaques ( fig. 3 c) .
In two of the normal brains flotillin-1-IR was found in single astrocytes of the gray matter ( fig. 3 d) . The others showed only slight diffuse staining of the extracellular matrix. Flotillin-1 was usually not detected in neurons, oligodendroglia and microglia of normal controls. The case with Parkinson's disease did not differ from the normal control cases ( fig. 3 e) . Negative reaction controls showed no flotillin-1-IR ( fig. 3 f) . The cases with AD showed two distinct partially overlapping patterns of flotillin-1-IR. There was expression of the protein in pathologically altered neurons and in association with neurofibrillary tangles. Diffuse ␤ -amyloid plaques without neurofibrils showed only minimal expression of flotillin-1. By morphological criteria expression of flotillin-1 in astrocyte processes appeared to be associated with astrocyte activation. These results show that flotillin-1 is present in extracellular ␤ -amyloid plaques and in tanglebearing neurons.
Discussion
Our present study shows that intracellular A ␤ accumulates in a subset of endocytic vesicles that are positive for the lipid raft-associated protein, flotillin-1. In ArcA ␤ mice, which exhibit consistent behavioral deficits before the deposition of ␤ -amyloid plaques, these A ␤ -laden endocytic vesicles might be involved in the mechanisms causing the cognitive impairment. We and others previously reported that generation of A ␤ occurs in early endosomes after endocytosis of APP [16] [17] [18] [19] where ␤ -and ␥ -cleavage occurs [20] . We also showed that A ␤ produced in early endosomes is retrogradely transported to late en- dosomes/MVBs [16] . As a result of the fusion of MVBs with the plasma membrane, the intraluminal vesicles of MVBs are released into extracellular space as exosomes. We hypothesized that the A ␤ associated with exosomes could act as a nucleation factor for amyloid plaque formation. Our current work shows that preceding the detection of extracellular plaque formation, A ␤ accumulates intracellularly in punctate structures that are frequently surrounded by flotillin-1 immunoreactivity. We conclude that the intracellular A ␤ structures detected in ArcA ␤ mice represent membrane-delimited endosomal compartments. The fact that we did not observe constant increases in intracellular A ␤ with increasing age of the animals would then implicate that intracellularly generated A ␤ does not irreversibly accumulate in neurons. A ␤ could be removed by degradative pathways (autophagosomes) [21] or even exocytosed via exosomes [16] into the extracellular space, affecting synaptic transmission [22, 23] . What is the significance of intracellular A ␤ trapped in these endosomal structures? MVBs have been shown to present an optimal environment for fibrillation of Pmel1, an amyloid-forming protein that is involved in melanosome biogenesis and melanin polymerization [24] . Though our current study has not provided any evidence for A ␤ oligomers/fibrils in these vesicles, it is tempting to propose that a similar mechanism could exist whereby intracellular A ␤ oligomerizes already in MVBs. Flotillin-1 could stabilize these compartments or could also act as a raft scaffolding protein and thereby promote amyloidogenic cleavage in raft domains [19] . Furthermore, flotillin-1 has been shown to interact directly with APP [25] and several groups reported the presence of flotillin-1 in ␤ -amyloid plaques [26] [27] [28] , supported by our current findings.
To summarize, A ␤ is generated in early endosomes and is retrogradely transported to the flotillin-1 containing late endosomes/MVBs. A ␤ may undergo oligomerization in these raft-enriched structures, stabilized by flotillin, and could be subsequently released from the cells via exosomes, affecting synapse function. Furthermore, these exosome-associated A ␤ could form a nucleation center for ␤ -amyloid plaque formation.
